A target of the anti-tuberculosis drugs isoniazid (INH) and ethionamide (ETH
INTRODUCTION
Tuberculosis is one of the world's most deadly infectious diseases (World Health Organization, 1997) . The recent emergence of multidrug-resistant strains of Mycobacterium tuberculosis poses a serious threat to tuberculosis-control programs worldwide (Snider et al., 1994) . Understanding the mechanisms of resistance to the available antimycobacterial drugs and discovery of new drug targets are necessary for the treatment of tuberculosis. The gene (inhA) encoding a target for isoniazid (INH) and its analogue, ethionamide (ETH), was cloned in M . tuberculosis, it was not initially tested whether MabA from M . tuberculosis plays a role in mediating drug resistance. Based on the high (82% identity) homology between these two MabAs, it was assumed that M . tuberculosis MabA is not involved in INH resistance. However, later on, INH-resistant clinical isolates of M. tuberculosis were frequently reported to have mutations in the ribosome-binding site (RBS) of ma6A (Kapur et al., 1996; Musser et al., 1996; Rouse et al., 1995; Telenti et al., 1997; Victor et al., 1997) . This observation supported the speculation that, in M. tuberculosis, MabA could be an additional target for INH and ETH, and overexpression of MabA could mediate INH resistance by virtue of increased drug titration (Musser, 1995) . Hence, we decided to characterize the mabA-encoded activity and examined, by a genetic approach, whether it can be a target for INH and ETH in M. tuberculosis.
METHODS
Strains, plasmids and media. Strains and plasmids used in this study are shown in Table 1 . All the antibiotics used were purchased from Sigma if not mentioned otherwise. Luria broth (Difco) and Luria agar containing 50 pg ampicillin ml-' were used for the growth of Escherichia coli strains (Sambrook et al., 1989) . Mycobacteria were grown in liquid culture using M-OADC-TW broth (Jacobs et al., 1991) . Middlebrook 7H10 agar (supplemented with 10 '/o OADC and 0.5 '/o glycerol) was used for growth on solid media, colony titrations and plating transformations of mycobacteria. Selections for mycobacteria were performed using this solid medium containing kanamycin (10-25 pg ml-'), I N H (0.2, 1, 10,20 and 50 pg m1-l) and ETH (10, 30, 50, 100 and 200 pg ml-l). Cycloheximide was added to liquid and solid media at a final concentration of 50 pg ml-l to inhibit growth of moulds.
DNA manipulation, cloning and sequencing. The original M. smegmatis mabA-inhA cosmids were isolated from a M. smegmatis genomic library by their ability to confer INH resistance in the M. smegmatis host (Banerjee et al., 1994) . Analogous M. tubercu[osis and Mycobacterium bovis BCG cosmids were obtained by screening genomic libraries of these two organisms using colony blotting. The plasmids used in this study (Table 1) are subclones of these parent cosmids. For subcloning, cosmid DNAs were digested with the restriction enzymes (New England Biolabs) indicated in Table 1 , and the desired DNA fragments were isolated by using the GENECLEAN I1 kit (Bio 101) after electrophoresis on a 1 '/o SEAKEM (FMC) agarose gel following the manufacturer's DpnI fragment carrying the CAT gene (Bartolome et al., 1991) 
inserted into
Derivative of pYUB376 with a truncated inhA gene produced by digestion
As pYUB630 except that the XbaI-Hind111 fragment is from M. bovis BCG inhA genes and HindIII (Fig. 4) the SphI site of mabA of pYUB630 ( Fig. 4) with BsaBI and HindIII (Fig. 4) . The N-terminal primer contained the first 24 bp of the mabA coding sequence and an NcoI restriction site overlapping the initiation codon. The C-terminal primer contained a HindIII restriction site, the termination codon and 20 bp of the mabA anti-codon sequence. The PCR reactions contained 6 ng template DNA, 1.5 pg each primer, 200 pM dNTPs, 10 p1 l o x buffer for Taq polymerase, 5 units Taq polymerase, 7 mM MgCl, and 10% DMSO (Perkin Elmer) in a total volume of 100 pl. The reactions were incubated at 94 "C for 1.5 min, 62 "C for 1.5 min and 72 "C for 1.5 min for 30 cycles. The products were separated on a 1 % SEAKEM agarose (FMC) gel and a 744 bp PCR product was recovered using the GENECLEAN I1 kit (BIO 101).
The PCR product was cut with NcoI and HindIII and ligated into the previously cut and gel-purified pET3d ( ml-' and 34 pg chloramphenicol ml-' was inoculated with 120 ml overnight culture. The cells were grown at 37 "C to an OD,,, of approximately 0.7. IPTG was added to a final concentration of 1 mM to induce transcription of the T7
polymerase. The cells were harvested by centrifugation at 5000 r.p.m. (Sorvall GS-3 rotor) 2.5 h after induction. Cells were resuspended in lysis buffer containing 50 mM Tris/HCl, pH 8.0, 1 mM EDTA, 0*5O/0 Nonidet P-40 and 10 mM DTT (Sigma). The suspension was recentrifuged at 20000 r.p.m. for 1 h in a Sorvall SS-34 rotor at 4 "C to remove the cell debris. Nucleic acids were removed from the cell-free extract by 1 ' / o streptomycin sulfate precipitation, followed by centrifugation at 20000r.p.m. in a Sorvall SS-34 rotor for 1 h at 4 "C. The resulting supernatant was dialysed against 20 mM TAE, p H 7.8, overnight at 4 "C. The resulting soluble extracts were analysed by gel electrophoresis using 10-15 '/o gradient polyacrylamide PhastGel (Pharmacia) along with the LMW molecular mass standard (Pharmacia) .
KAR assays were performed in a quartz cuvette at 30 "C in a final volume of 1 ml with the following components: 1 mM acetoacetyl-CoA (Sigma), 40 mM HEPES, p H 7.0, and 150 pM NADH or NADPH. Normalized enzyme samples (20 pl) from induced or uninduced cellular extracts mentioned above were added to the reaction mixture. The conversion of NADH or NADPH to NAD or NADP was measured spectrophotometrically as the reduction in A340 by a continuous scanning method using a UVIKON 933 spectrophotometer (Kontron Instruments). The activity tests were then repeated with increasing concentrations of the induced extract using NADPH. Thereafter, initial velocities (pmol NADPH min-') of these reactions were plotted as a function of cell extract concentration. The volume of the extract used from the induced cells was 10, 15, 20 and 30 pl. The assays were repeated on the same extracts without the acetoacetyl-CoA substrate and without the NADH/NADPH cofactor as appropriate controls. Determination of the MIC of INH and ETH to mycobacterial strains. MIC assays were performed following a modification of our previously published assay (Banerjee et al., 1994) . In short, mycobacterial cells bearing the indicated plasmids were grown in M-OADC-TW containing kanamycin (15 pg ml-') and dilutions were plated on 7H10 agar plates containing kanamycin (15 pg ml-') alone or kanamycin with various concentrations of INH or ETH. The strains without any plasmid were grown in M-OADC-TW broth, and dilutions were plated on 7H10 agar plates and 7H10 agar plates containing various concentrations of INH or ETH. Here, MIC is defined as the concentration of the drug that produced > 99 ' / o inhibition of bacterial growth when inocula of -1000 organisms were plated. Similar sized inocula were used in every assay because MICs to INH and ETH vary considerably with large variations in inoculum.
RESULTS

Cloning and characterization of mabA genes from M. smegmatis, M. tuberculosis and M. bovis BCG
The report of cloning the inhA gene indicated the presence of an ORF, orfl/mabA, upstream of inhA in M . tu6erculosis, M . bouis and M. smegmatis (Banerjee et al., 1994) . Also, in that report, subcloning analysis demonstrated that, unlike in M. smegmatis, these two genes form an operon in M. tu6ercuZosis and M . 6ovis. Cosmid clones were identified at that time which contained both ma6A and inhA from these bacteria. In this study, parts of these cosmid inserts containing ma6A were subcloned into pBluescript I1 KS( + ) ( Table  1 ) and the sequence upstream of inhA was determined (Fig. 1) . We compared these sequences with each other, as well as with the recently released mabA sequence (accession no. AF002133) from Mycobacterium avium. The DNA region between the end of mabA and the 
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Conservation of ma6A and MabA among different myco bacteria
As in inhA (Banerjee et al., 1994) , we found that the DNA sequence of the mabA gene from M . tuberculosis is identical to that of M . bovis BCG (Fig. 1) ; we will therefore refer to these two genes as M. tuberculosis mabA. Despite the difference in gene organization and translational start site, the mabA gene appears to be highly conserved between different mycobacteria. At the DNA level, the identity was approximately 80% (Fig.  l) , which is in agreement with the high degree of homology indicated by the Southern blot using a fragment containing mabA. In all the 11 mycobacteria tested thus far, including important pathogens like M ycobacterium leprae, M . avium and M ycobacterium intracellulare, bands hybridizing with the M. smegmatis ma6A probe were observed (data not shown). Such conservation of mabA among various mycobacteria is consistent with our repeated failure to produce a knockout of this gene in M. smegmatis. However, the chromosomal gene could easily be knocked out when an extra episomal copy was present (data not shown). These results indicate that MabA is likely to be essential, like InhA.
At the amino acid level (Fig. 2) 
Homology of MabA amino acid sequence with other KARs that are available in the database
A TFASTA (Genetics Computer Group, 1995) search was performed on the EMBL and GenBank databases, using both the amino acid sequences. The search revealed that the best homologies to MabA are KARs from E. coli (Rawlings & Cronan, 1992) , Vibrio harueyi (Shen & Byers, 1996) and Haemophilus infiuenxae (Fleischmann et al., 1995) . The sequence alignment of these three fatty acid biosynthesis enzymes with the three MabA sequences is shown in Fig. 2 . The identity between the MabAs and the KARs is approximately 40% and the total similarity is about 60 Yo. In addition, the KAR counterparts from plants, the /?-ketoacyl-ACP reductases of Cuphea lanceoleta (Klein et al., 1992) , Arabdopsis thaliana and Brassica napus (Slabas et al., 1992) , show strong homology ( -3 5 4 0 YO identity) to the two MabA sequences.
Overexpression of MabA and biochemical determination of its activity
The 744 bp insert in the pET3d-ma6A construct was verified by sequencing and found to match the wild-type ma6A sequence. To verify the function of the reading frame in the construct, pET3d-ma6A was transformed into BL21 (DE3)pLysS, a lysogenic strain containing the gene for T7 RNA polymerase under the control of a lacUV5 promoter. Cell-free extracts made from cultures after 2.5 h with or without induction by 1 mM IPTG were examined by PAGE. The IPTG-induced cells harbouring pET3d-mabA showed moderate overexpression of a 28 kDa protein (data not shown) which matched the predicted molecular mass of 25665 Da. This protein band was not seen in extracts of uninduced cells or control cells without plasmids. 
uninduced cell extract+NADH, (3) uninduced cell extract+ NADPH, (4) induced cell extract+ NADH and (5) induced cell extract+ NADPH.
The soluble extracts from both induced and uninduced strains were assayed for KAR activity. The extracts were tested in the presence of either NADH or NADPH. By a continuous scanning spectrophotometric assay, using both cofactors, the extracts from the induced cells were found to have considerable KAR activity (Fig. 3) . However, the enzyme demonstrated a definite preference for NADPH, as seen by the sevenfold increase in activity in the presence of this substrate. This definite preference for NADPH agrees with the presence of an NADPbinding motif (Hanukoglu & Gutfinger, 1989) in MabA (Fig. 2) . The extract from the uninduced cells showed no significant activity although there could be some back- ground activity from the E. coli KAR. The host activity is probably not observed because the E. coli KAR, which preferentially uses acetoacetyl-ACP, has been reported to have very poor activity with acetoacetyl-CoA as substrate (Toomey & Wakil, 1966) . In addition, induction of this activity by IPTG clearly distinguished the KAR of M. tuberculosis from any background contaminant from the E. coli host or other contaminating activities in the extract. The activity tests were then repeated with increasing concentrations of the induced extract and demonstrated a linear dependence (data not shown) of activity on the amount of the induced extract (i.e. MabA protein concentration) to further support the claim that the observed KAR activity is indeed from the induced MabA protein.
Examination of the multiple copy effect of M. tuberculosis mabA on INH-ETH resistance
New plasmids were constructed based on the mycobacteria-E. coli shuttle vector pMD3 1 (Donnelly-Wu et al., 1993) to separate mabA from inhA (Fig. 4) . The first of these new plasmids, pYUB630, is a derivative of a previously published plasmid, pYUB376 (Table 1) . It contains the entire mabA-inhA locus but none of the extra DNA present 3' of inhA in pYUB376 and it confers the INH-ETH-resistance phenotype in the M. smegmatis mc2155 host by raising the MICINH to 15 pg ml-l and MICE,, to 30 pg ml-l from the wild-type values of 5 pg ml-' and 10 pg ml-l (Fig. 4) . A chloramphenicol acetyltransferase (CAT) cassette (Bartolome et al., 1991) was inserted into mabA in pYUB630. The CAT fragment is known to be nonpolar and does not carry any terminator of transcription. Hence, this insertion should not interfere with the expression of inhA. This construct with a defective mabA but a wild-type inhA was designated pYUB63 1. When introduced into mc2155, pYUB631 conferred the same resistance phenotype as pYUB630. pYUB632 contains a wild-type mabA and a truncated inhA. This plasmid failed to confer any drug resistance upon the host. The cloning vector pMD31 by itself did not confer any resistance to INH and ETH when introduced into mc2155. In addition, pYUB632
was tested in M. bovis BCG, where it also failed to show any enhanced resistance over the pMD31 vector control (MICIN, 0.2 pg ml-').
The results discussed above clearly show that interruption of M. tuberculosis mabA without affecting inhA does not interfere with the ability of the plasmid to confer INH-ETH resistance. However, a deletion of the inhA locus while keeping mabA intact causes a complete loss of the resistance phenotype. Therefore, unlike the overexpression of M. tuberculosis InhA, the overexpression of MabA from M. tuberculosis does not show the ability to titrate INH and ETH.
DISCUSSION
In M. tuberculosis and M. bovis, mabA and inhA are in one operon whereas in M. smegmatis (and probably in M. avium) these two genes are independently transcribed (Banerjee et al., 1994) . As discussed in the Introduction, MabA from M. tuberculosis was suggested as a possible target for INH, mainly due to frequent observations of mutations at the RBS of mabA in many clinical INH-resistant M. tuberculosis isolates (Musser, 1995 (Baldock et al., 1996) . Similarly, the knowledge of the MabA activity together with the ability to overexpress this highly conserved protein presents the mabA-encoded KAR as a potential target for developing new drugs. Additionally, further biochemical and structural characterization of this KAR may also lead to greater insight into the as yet unknown but important biology of mycolic acid biosynthesis.
